Amphotericin B in neonates: deoxycholate or lipid formulation as first-line therapy – is there a ‘right’ choice?

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Nephrotoxicity Associated With Amphotericin B Deoxycholate in Neonates

(2009) Jennifer Le et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Antimicrobial policies in the neonatal units of the United Kingdom and Republic of Ireland

(2008) A. M. R. Fernando et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Micafungin Versus Liposomal Amphotericin B for Pediatric Patients With Invasive Candidiasis

(2008) Flavio Queiroz-Telles et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Pediatric Antifungal Utilization

(2008) Priya A. Prasad et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Influence of sodium intake on Amphotericin B-induced nephrotoxicity among extremely premature infants

(2008) Rodica Turcu et al.   PEDIATRIC NEPHROLOGY